AstraZeneca Italy

AstraZeneca Italy is owned by AstraZeneca.

AstraZeneca is one of the...

AstraZeneca is a company listed under the stock ticker AZN (GB).

AstraZeneca has a direct presence in 31 countries.

They are in:

Acquisition, funding and merger involving AstraZeneca.

AstraZeneca has announced the acquisition of Fusion Pharma (posted on March 23 2024).
AstraZeneca has announced the acquisition of Amolyt Pharma (posted on March 19 2024).
AstraZeneca has acquired Gracell Biotechnologies (posted on February 23 2024).
AstraZeneca has acquired CinCor Pharma (posted on January 10 2023).
AstraZeneca has announced the acquisition of Neogene Therapeutics (posted on November 29 2022).
See more news about AstraZeneca Hide news involving AstraZeneca

View the org chart displaying its 4 main executives

Menelas Pangalos, Executive Vice President, Research and Development BioPharmaceuticals, will leave the company on Jan. 1, 2024 (posted on July 28 2023).
Sharon Barr who is Senior Vice President and Head of Research & Product Development, Alexion, will be promoted to Executive Vice President, BioPharmaceuticals R&D on Aug. 1, 2023 (posted on July 28 2023).

Create your alert
to follow the executive moves at AstraZeneca Italy.